Next Article in Journal
High-Level Expression of Recombinant VHSV Glycoprotein Using Transformed C. vulgaris and Verification of Vaccine Efficacy
Next Article in Special Issue
Characterization of Brucella abortus Mutant A19mut2, a Potential DIVA Vaccine Candidate with a Modification on Lipopolysaccharide
Previous Article in Journal
The Burden of Genital Warts in Finland: Cross-Sectional Analysis of the Prevalence and Direct Medical Costs in 2018
Previous Article in Special Issue
A Booster with a Genotype-Matched Inactivated Newcastle Disease Virus (NDV) Vaccine Candidate Provides Better Protection against a Virulent Genotype XIII.2 Virus
 
 
Brief Report

Article Versions Notes

Vaccines 2023, 11(7), 1204; https://doi.org/10.3390/vaccines11071204
Action Date Notes Link
article xml file uploaded 5 July 2023 12:46 CEST Original file -
article xml uploaded. 5 July 2023 12:46 CEST Update https://www.mdpi.com/2076-393X/11/7/1204/xml
article pdf uploaded. 5 July 2023 12:46 CEST Version of Record https://www.mdpi.com/2076-393X/11/7/1204/pdf
article html file updated 5 July 2023 12:47 CEST Original file -
article html file updated 5 July 2023 12:47 CEST Update -
article html file updated 20 July 2023 20:40 CEST Update https://www.mdpi.com/2076-393X/11/7/1204/html
Back to TopTop